Mereo BioPharma Group Plc (MREO)
0.291
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
0.291
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Debt to Equity Ratio : 0.0359 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0359 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.0049 |
| September 30, 2025 | 0.0085 |
| June 30, 2025 | 0.0111 |
| Date | Value |
|---|---|
| March 31, 2025 | 0.0124 |
| December 31, 2024 | 0.1054 |
| September 30, 2024 | 0.0921 |
| June 30, 2024 | 0.0783 |
| March 31, 2024 | 0.1405 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 0.0332 |
| BioNTech SE | 0.0178 |
| Silence Therapeutics Plc | 0.0029 |
| Autolus Therapeutics Plc | 4.915 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 34.71M |
| Total Liabilities (Quarterly) | 6.062M |
| Shareholders Equity (Quarterly) | 28.65M |
| Current Ratio | 5.884 |
| Net Debt Paydown Yield | -0.11% |